Catuogno Silvia, Esposito Carla Lucia
Istituto di Endocrinologia ed Oncologia Sperimentale "G. Salvatore", CNR, Naples 80100, Italy.
Biomedicines. 2017 Aug 14;5(3):49. doi: 10.3390/biomedicines5030049.
Aptamers are high affinity single-stranded DNA/RNA molecules, produced by a combinatorial procedure named SELEX (Systematic Evolution of Ligands by Exponential enrichment), that are emerging as promising diagnostic and therapeutic tools. Among selection strategies, procedures using living cells as complex targets (referred as "cell-SELEX") have been developed as an effective mean to generate aptamers for heavily modified cell surface proteins, assuring the binding of the target in its native conformation. Here we give an up-to-date overview on cell-SELEX technology, discussing the most recent advances with a particular focus on cancer cell targeting. Examples of the different protocol applications and post-SELEX strategies will be briefly outlined.
适体是通过名为SELEX(指数富集配体系统进化)的组合程序产生的高亲和力单链DNA/RNA分子,正成为有前景的诊断和治疗工具。在筛选策略中,已开发出以活细胞作为复杂靶标的程序(称为“细胞SELEX”),作为一种有效的方法来生成针对高度修饰的细胞表面蛋白的适体,确保靶标以其天然构象结合。在此,我们对细胞SELEX技术进行了最新概述,讨论了最新进展,特别关注癌细胞靶向。将简要概述不同方案应用和SELEX后策略的示例。